Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLTC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PTRH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YPEL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMG8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on